Literature DB >> 29355062

Effects of gestational and pregestational diabetes mellitus on the foetal heart: a cross-sectional study.

Pinar Dervisoglu1, Mustafa Kosecik1, Serkan Kumbasar2.   

Abstract

We examined the foetal cardiac structural and functional characteristics in diabetic pregnancies versus non-diabetic, healthy pregnancies. Between August 2015 and April 2016, 32 pregnant women with pregestational diabetes, 36 pregnant women with gestational diabetes, and 42 healthy pregnant women were scheduled to have foetal echocardiograms to assess cardiac structure and function. In the diabetic groups, the foetal interventricular septum (IVS) thickness was significantly greater than in non-diabetics (p < .05) but none had an IVS >2 SD from normal. The peak velocity of tricuspid E, and the E/A ratio were significantly lower in the diabetic groups (p < .05). Tricuspid valve Ea values and the Ea/Aa ratio were lower in the diabetic group than in the control group (p < .05) but there was no significant difference between the pre-GDM and GDM groups (p > .05). Interventricular septal hypertrophy is the most common structural abnormality in diabetic pregnancies. These changes do not pose a risk to the foetal unless they cause functional impairment. Thus, we believe that it is important for diabetic pregnant women to be monitored for foetal cardiac diastolic dysfunction. Impact statement What is already known on this subject? Pregestational insulin-dependent diabetes mellitus is a relatively common condition in pregnancy, affecting up to 0.5% of the pregnant population. Foetuses of diabetic mothers are at an increased risk of perinatal morbidity and death. Gestational diabetes mellitus is under-recognised and affects up to 4% of pregnancies. Although diabetes mellitus is known to increase the risk of cardiovascular defects and structural changes (myocardial hypertrophy and diastolic dysfunction) due to foetal hyperglycaemia and hyperinsulinism, similar data in women with gestational diabetes is scarce. Moreover, the effect of maternal hyperglycaemia on foetal cardiac structure and function is unclear because of discordant results from previous studies. What do the results of this study add? In this study, we have used foetal echocardiography, two-dimensional US, pulsed wave Doppler and TDI to characterise the foetal cardiac structure and function in normal pregnancies as well as in the pregnancies complicated by GDM, and pregestational DM. Interventricular septum thickness is increased in women with pregestational diabetes mellitus and impaired diastolic function. The dominant right ventricle of the foetal circulation was affected earlier than the left ventricle. What are the implications of these findings for clinical practice and/or further research? Large population-based studies are required to establish the absolute risk of congenital heart defects in patients with pregestational diabetes and pregestational diabetes in the utility of routine screening.

Entities:  

Keywords:  Gestational diabetes mellitus; diastolic dysfunction; foetal echocardiography; interventricular septum thickness

Mesh:

Substances:

Year:  2018        PMID: 29355062     DOI: 10.1080/01443615.2017.1410536

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  9 in total

Review 1.  Impact of maternal hyperglycemia on cardiac development: Insights from animal models.

Authors:  Talita Z Choudhury; Uddalak Majumdar; Madhumita Basu; Vidu Garg
Journal:  Genesis       Date:  2021-09-09       Impact factor: 2.487

Review 2.  Effect of maternal pregestational diabetes mellitus on congenital heart diseases.

Authors:  Zhi-Yan Chen; Shuang-Fa Mao; Ling-Hong Guo; Jian Qin; Li-Xin Yang; Yin Liu
Journal:  World J Pediatr       Date:  2022-07-15       Impact factor: 9.186

3.  Effect of gestational diabetes and insulin resistance on offspring's myocardial relaxation kinetics at three years of age.

Authors:  Samuel Blais; Julie Patenaude; Myriam Doyon; Luigi Bouchard; Patrice Perron; Marie-France Hivert; Frederic Dallaire
Journal:  PLoS One       Date:  2018-11-21       Impact factor: 3.240

4.  Epigenetic Down-Regulation of Sirt 1 via DNA Methylation and Oxidative Stress Signaling Contributes to the Gestational Diabetes Mellitus-Induced Fetal Programming of Heart Ischemia-Sensitive Phenotype in Late Life.

Authors:  Zewen Chen; Lei Gong; Peng Zhang; Yong Li; Bailin Liu; Lubo Zhang; Jian Zhuang; Daliao Xiao
Journal:  Int J Biol Sci       Date:  2019-05-11       Impact factor: 6.580

5.  Fetal echocardiography at term in diabetic pregnancies helps predict the adverse neonatal outcome - Results of a prospective observational study from South India.

Authors:  Grandhi Mrudhula Tejaswi; Jyothi Samanth; Akhila Vasudeva; Leslie Lewis; Pratap Kumar; Krishnananda Nayak; R Padmakumar
Journal:  Indian Heart J       Date:  2020-10-06

6.  Genome-wide analysis of methylation in rat fetal heart under hyperglycemia by methylation-dependent restriction site-associated DNA sequencing.

Authors:  Rui Meng; Junxian Song; Lina Guan; Qian Li; Cuige Shi; Dongmei Su; Xu Ma
Journal:  PLoS One       Date:  2022-05-11       Impact factor: 3.752

7.  Post-COVID-19 fetal cardiac evaluation in moderate infection group of pregnant women.

Authors:  Sule Goncu Ayhan; Ezgi Turgut; Eda Ozden Tokalioglu; Deniz Oluklu; Bedri Sakcak; Derya Uyan Hendem; Atakan Tanacan; Ozlem Moraloglu Tekin; Dilek Sahin
Journal:  J Clin Ultrasound       Date:  2022-05-07       Impact factor: 0.869

8.  Assessment of fetal cardiac diastolic function of gestational diabetes mellitus using dual-gate Doppler.

Authors:  Qingsha Hou; Fang Yan; Xudong Dong; Huanling Liu; Jie Wu; Jiao Li; Yunchuan Ding
Journal:  Medicine (Baltimore)       Date:  2021-07-16       Impact factor: 1.817

9.  Effect of maternal diabetes on fetal heart function on echocardiography: systematic review and meta-analysis.

Authors:  A L Depla; L De Wit; T J Steenhuis; M G Slieker; D N Voormolen; P G Scheffer; R De Heus; B B Van Rijn; M N Bekker
Journal:  Ultrasound Obstet Gynecol       Date:  2021-04       Impact factor: 7.299

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.